February 27, 2024 · Form 4 insider transaction
Reich Kristian sold 29,431 shares of MOONLAKE THERAPEUTICS at $55.00 per share, a transaction worth $1.62M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 16, 2023.